Clinical Trials Browser

Withdrawn × liposomal doxorubicin × Gastrointestinal × Clear all

NCT02527772 2019-06-04

LD-FOX4/HCC

Phase 2/3 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

NCT01281943 2013-07-04

Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer

Phase 2 Withdrawn

Gastrointestinal

Liver Neoplasms